Immunosolv Limited, Edinburgh, EH16 4SB, UK.
MAbs. 2009 Jul-Aug;1(4):370-6. doi: 10.4161/mabs.1.4.9124. Epub 2009 Jul 28.
Cells undergoing apoptosis in vivo are rapidly detected and cleared by phagocytes. Swift recognition and removal of apoptotic cells is important for normal tissue homeostasis and failure in the underlying clearance mechanisms has pathological consequences associated with inflammatory and auto-immune diseases. Cell cultures in vitro usually lack the capacity for removal of non-viable cells because of the absence of phagocytes and, as such, fail to emulate the healthy in vivo micro-environment from which dead cells are absent. While a key objective in cell culture is to maintain viability at maximal levels, cell death is unavoidable and non-viable cells frequently contaminate cultures in significant numbers. Here we show that the presence of apoptotic cells in monoclonal antibody-producing hybridoma cultures has markedly detrimental effects on antibody productivity. Removal of apoptotic hybridoma cells by macrophages at the time of seeding resulted in 100% improved antibody productivity that was, surprisingly to us, most pronounced late on in the cultures. Furthermore, we were able to recapitulate this effect using novel super-paramagnetic Dead-Cert Nanoparticles to remove non-viable cells simply and effectively at culture seeding. These results (1) provide direct evidence that apoptotic cells have a profound influence on their non-phagocytic neighbors in culture and (2) demonstrate the effectiveness of a simple dead-cell removal strategy for improving antibody manufacture in vitro.
体内正在凋亡的细胞会被吞噬细胞迅速检测并清除。快速识别和清除凋亡细胞对于正常的组织稳态很重要,而潜在清除机制的失败会导致与炎症和自身免疫性疾病相关的病理后果。由于缺乏吞噬细胞,体外细胞培养通常缺乏清除非存活细胞的能力,因此无法模拟不存在死亡细胞的健康体内微环境。虽然细胞培养的一个关键目标是将细胞活力保持在最高水平,但细胞死亡是不可避免的,而且非存活细胞经常以大量的方式污染培养物。在这里,我们表明,凋亡细胞的存在对单克隆抗体产生杂交瘤培养物的抗体产生能力有明显的不利影响。在接种时通过巨噬细胞去除凋亡的杂交瘤细胞,可使抗体产生能力提高 100%,令人惊讶的是,这种效果在培养后期最为明显。此外,我们使用新型超顺磁 Dead-Cert 纳米颗粒在培养物接种时简单有效地去除非存活细胞,从而重现了这种效果。这些结果 (1) 提供了直接证据,证明凋亡细胞对其非吞噬性细胞邻居在培养中有深远的影响,(2) 证明了一种简单的清除死细胞策略在体外提高抗体生产的有效性。